Imogen Fitt[email protected]HomeWhy best-of-breed LIS vendors might yet survive EHR’s invasionIs EHR-based LIS therefore a foregone conclusion? Or is there a place still for dedicated BoB-LIS? Based on our latest research assessing the global LIS market, the evidence points to a surprisingly bright future for BoB-LIS.May 30, 2022Pathology, histologyDigital pathology: What does the future hold?There are unique circumstances causing this, including a combination of overregulation, tight reimbursement, and a lack of evidence for tangible cost savings. However, even despite this, pathology's dwindling workforce and increasing caseloads have always made the case for digitization's seeming inevitability.Table 1: Digital pathology drivers and barriers. 1= Least important, 10 = Most important.Table 1: Digital pathology drivers and barriers. 1= Least important, 10 = Most important.December 20, 2021Artificial IntelligenceVenture capital funding for digital pathology tops $860MInvestment is now evolving to focus on startups developing artificial intelligence (AI) solutions for digital pathology image analysis.Image courtesy of Signify.Image courtesy of SignifyApril 26, 2021Page 1 of 1Top StoriesImmunoassaysLucy Letby murder case flags immunoassays as unreliable for medical evidenceAt least one pathologist has said it was wrong for scientists representing Liverpool Clinical Laboratories to insist insulin poisoning was the only explanation in a series of high-profile newborn deaths in the U.K., The Telegraph reported.Pathology and AIDigital pathology rollouts race for proof-of-concept at national levelBiomarker Discovery & ValidationCaris Life Sciences embarks on 10K-sample breast cancer biomarker analysis projectFederal LegislationASCLS seeks support for med lab personnel actSponsor ContentBody composition in patients treated with Ozempic